Evidence map›Paper›PMID 9819385›Full record

ArticleMolecular and cellular biology1998

Requirement of atypical protein kinase clambda for insulin stimulation of glucose uptake but not for Akt activation in 3T3-L1 adipocytes.

K Kotani, W Ogawa, M Matsumoto, T Kitamura, H Sakaue, Y Hino, K Miyake, W Sano, K Akimoto, S Ohno and 1 more

Open access · greenAbstract read
In one paragraph

Article in Molecular and cellular biology, 1998. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 81 papers.

0numbers the graph read from it
0cells of the map it votes in
81citing papers in PubMed
12.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

81 citing papers in PubMed, 360 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Review
  4. Article
  5. Insulin signaling in health and disease.The Journal of clinical investigation · 2021
    Review
  6. Review
  7. Article
  8. Article
  9. Protein kinase C: perfectly balanced.Critical reviews in biochemistry and molecular biology · 2018
    Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Protein Scaffolds Control Localized Protein Kinase Cζ Activity.The Journal of biological chemistry · 2016
    Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article

21 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

K KotaniSecond Department of Internal Medicine, Kobe University School of Medicine, Chuo-ku, Kobe 650-0017, Japan.
W Ogawa
M Matsumoto
T Kitamura
H Sakaue
Y Hino
K Miyake
W Sano
K Akimoto
S Ohno
M Kasuga
Kobe University · JPYokohama City University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Phosphoinositide (PI) 3-kinase contributes to a wide variety of biological actions, including insulin stimulation of glucose transport in adipocytes. Both Akt (protein kinase B), a serine-threonine kinase with a pleckstrin homology domain, and atypical isoforms of protein kinase C (PKCzeta and PKClambda) have been implicated as downstream effectors of PI 3-kinase. Endogenous or transfected PKClambda in 3T3-L1 adipocytes or CHO cells has now been shown to be activated by insulin in a manner sensitive to inhibitors of PI 3-kinase (wortmannin and a dominant negative mutant of PI 3-kinase). Overexpression of kinase-deficient mutants of PKClambda (lambdaKD or lambdaDeltaNKD), achieved with the use of adenovirus-mediated gene transfer, resulted in inhibition of insulin activation of PKClambda, indicating that these mutants exert dominant negative effects. Insulin-stimulated glucose uptake and translocation of the glucose transporter GLUT4 to the plasma membrane, but not growth hormone- or hyperosmolarity-induced glucose uptake, were inhibited by lambdaKD or lambdaDeltaNKD in a dose-dependent manner. The maximal inhibition of insulin-induced glucose uptake achieved by the dominant negative mutants of PKClambda was approximately 50 to 60%. These mutants did not inhibit insulin-induced activation of Akt. A PKClambda mutant that lacks the pseudosubstrate domain (lambdaDeltaPD) exhibited markedly increased kinase activity relative to that of the wild-type enzyme, and expression of lambdaDeltaPD in quiescent 3T3-L1 adipocytes resulted in the stimulation of glucose uptake and translocation of GLUT4 but not in the activation of Akt. Furthermore, overexpression of an Akt mutant in which the phosphorylation sites targeted by growth factors are replaced by alanine resulted in inhibition of insulin-induced activation of Akt but not of PKClambda. These results suggest that insulin-elicited signals that pass through PI 3-kinase subsequently diverge into at least two independent pathways, an Akt pathway and a PKClambda pathway, and that the latter pathway contributes, at least in part, to insulin stimulation of glucose uptake in 3T3-L1 adipocytes.

Indexed as

Muscle ProteinsProtein Serine-Threonine Kinases3T3 CellsAdenoviridaeAdipocytesAndrostadienesAnimalsCOS CellsEnzyme ActivationFluorescent Antibody TechniqueGlucoseGlucose Transporter Type 4InsulinIsoenzymesMiceMonosaccharide Transport ProteinsAndrostadienesGlucoseGlucose Transporter Type 4InsulinIsoenzymesMonosaccharide Transport ProteinsMuscle ProteinsPhosphatidylinositol 3-KinasesProtein Kinase CProtein Kinase C-lambdaProtein Serine-Threonine KinasesProto-Oncogene ProteinsProto-Oncogene Proteins c-aktSlc2a4 protein, mouseWortmannin

Identifiers

PMID9819385
PMCPMC109280
OpenAlexW2147207624

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.